TickerFactsScreenerDevelopers

Eledon Pharmaceuticals, Inc. (ELDN) — Cash & Equivalents

Annual figures by fiscal year, from SEC filings.

2011: $2.25M2012: $11.69M2013: $31.75M2014: $105.26M2015: $24.02M2016: $1.10M2017: $17.23M2018: $12.97M2019: $8.79M2020: $114.19M2021: $84.83M2022: $56.41M2023: $4.61M2024: $20.55M2025: $22.81M$22.81M
2011Cash & Equivalents (USD)2025
Fiscal YearCash & EquivalentsChange YoY
2025$22.81M+11.0%
2024$20.55M+345.6%
2023$4.61M-91.8%
2022$56.41M-33.5%
2021$84.83M-25.7%
2020$114.19M+1199.0%
2019$8.79M-32.2%
2018$12.97M-24.7%
2017$17.23M+1462.4%
2016$1.10M-95.4%
2015$24.02M-77.2%
2014$105.26M+231.5%
2013$31.75M+171.6%
2012$11.69M+418.9%
2011$2.25M—